Pan-cancer analysis of GJB5 as a novel prognostic and immunological biomarker
Abstract Gap junction protein B5 (GJB5, also known as Connexin 31.1) has recently been reported to be downregulated in several cancer types, where it functions primarily as a tumor suppressor in cancers such as melanoma and non-small cell lung cancer (NSCLC). However, there no reports describing its...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-96389-6 |
